Lorca, Luz AlejandraSacomori, CinaraPuga, Bárbara2017-02-092017-02-092016-07Rev. méd. Chile vol.144 no.7 Santiago jul. 20160034-9887http://dx.doi.org/10.4067/S0034-98872016000700010http://repositorio.unab.cl/xmlui/handle/ria/2977Indexación: Web of Science, Scielo.Background: Fatigue is one of the most common and distressing symptoms experienced by cancer patients. Aim: To validate the Brief Fatigue Inventory in people treated for hematological neoplasms. Material and Methods: In a cross-sectional study, the Brief Fatigue Inventory was answered by 122 patients aged 40 +/- 14 years (50% women) treated for hematological neoplasms at an intensive hematological unit of a public hospital between July 2010 and July 2013. Socio-demographic and clinical parameters were obtained from their clinical records. Results: Fatigue was present in nearly all patients (99.2%) in minor (50%), moderate (36.9%) or severe (12.3%) levels. The average fatigue score was 4.5 +/- 1.9). The Brief Fatigue Inventory had a good internal consistency (Cronbach's alpha = 0.973) and proved to be one-dimensional (84.3% of the explained variance). Women reported that fatigue interfered more with enjoyment of life than men (p = 0.036). Conclusions: The Brief Fatigue Inventory is a reliable instrument that can be used in clinical practice. It allows a quick assessment of the level of fatigue. People treated for hematologic cancer have a high prevalence of fatigue.esSTEM-CELL TRANSPLANTATIONQUALITY-OF-LIFECANCER-PATIENTSPSYCHOMETRIC PROPERTIESVALIDATIONVERSIONTHERAPYPREVALENCEBFIArtículo